Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin

Published 2016 View Full Article

Authors

Keywords

Alzheimer's disease, β-amyloid, Intravenous immunoglobulin, Oligomers, Antibody

Journal

NEUROPHARMACOLOGY

Volume 105, Issue -, Pages 561-576

Publisher

Elsevier BV

Online

2016-02-20

DOI

10.1016/j.neuropharm.2016.02.015

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started